Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0179 USD | +1.33% | -21.15% | -30.89% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 75 | 14-01-31 | |
Evan Wasoff
DFI | Director of Finance/CFO | 77 | - |
Jeremy Reeh
CTO | Chief Tech/Sci/R&D Officer | - | 18-10-25 |
Robert Goldfarb
COO | Chief Operating Officer | 69 | - |
Frank Manganella
PRN | Corporate Officer/Principal | 58 | 18-10-29 |
Joseph Aceto
PRN | Corporate Officer/Principal | 66 | 18-10-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lindy Snider
BRD | Director/Board Member | 64 | 18-01-25 |
Chief Executive Officer | 75 | 14-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,472,196 | 30,966,703 ( 45.90 %) | 0 | 45.90 % |
Company contact information
Nexien BioPharma, Inc.
4340 East Kentucky Avenue Suite 206
80246, Glendale
+303 495 7583
http://www.nexienbiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
-30.89% | 1.21M | |
+32.11% | 693B | |
+29.39% | 584B | |
-2.72% | 372B | |
+20.43% | 332B | |
+6.67% | 294B | |
+13.83% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.81% | 168B |
- Stock Market
- Equities
- NXEN Stock
- Company Nexien BioPharma, Inc.